Matches in Wikidata for { <http://www.wikidata.org/entity/Q66391072> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q66391072 description "clinical trial" @default.
- Q66391072 description "ensayu clínicu" @default.
- Q66391072 description "klinisch onderzoek" @default.
- Q66391072 description "клінічне випробування" @default.
- Q66391072 description "կլինիկական փորձարկում" @default.
- Q66391072 name "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 name "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 type Item @default.
- Q66391072 label "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 label "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 prefLabel "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 prefLabel "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 P1132 Q66391072-B660EAC5-79AB-4EED-80BE-88AD8271A8A7 @default.
- Q66391072 P1476 Q66391072-DC3FC73A-F792-4F4F-9448-F7E8D3AE9FE7 @default.
- Q66391072 P17 Q66391072-A2198130-C8DB-4EDE-859F-6DC5013016B7 @default.
- Q66391072 P2899 Q66391072-183EEFBF-638F-430B-B68D-7CFA62F5D2EA @default.
- Q66391072 P3098 Q66391072-E6F723EF-8519-40E4-8718-B49AD1F0EC77 @default.
- Q66391072 P31 Q66391072-8CB5014F-BC26-45F9-A86D-85442B1B2682 @default.
- Q66391072 P4844 Q66391072-BA06A719-A78B-4F28-A276-2F0A9BCD3F8A @default.
- Q66391072 P580 Q66391072-2961DA71-0DA5-460B-9C05-6D3DD45C8C02 @default.
- Q66391072 P582 Q66391072-EC65C297-0E52-47A7-9A79-E91493B9BE2C @default.
- Q66391072 P6099 Q66391072-B8B5378C-E2DD-4294-90F9-517040959705 @default.
- Q66391072 P8363 Q66391072-907280BC-D517-468B-86C3-78285AF55100 @default.
- Q66391072 P1132 "+60" @default.
- Q66391072 P1476 "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer" @default.
- Q66391072 P17 Q30 @default.
- Q66391072 P2899 "+18" @default.
- Q66391072 P3098 "NCT03032406" @default.
- Q66391072 P31 Q30612 @default.
- Q66391072 P4844 Q32089 @default.
- Q66391072 P580 "2017-01-23T00:00:00Z" @default.
- Q66391072 P582 "2022-01-23T00:00:00Z" @default.
- Q66391072 P6099 Q42824440 @default.
- Q66391072 P8363 Q78089383 @default.